Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,796 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT.
Senjo H, Harada S, Kubota SI, Tanaka Y, Tateno T, Zhang Z, Okada S, Chen X, Kikuchi R, Miyashita N, Onozawa M, Goto H, Endo T, Hasegawa Y, Ohigashi H, Ara T, Hasegawa Y, Murakami M, Teshima T, Hashimoto D. Senjo H, et al. Among authors: hasegawa y. Blood. 2023 Aug 3;142(5):477-492. doi: 10.1182/blood.2023019875. Blood. 2023. PMID: 37216687 Free article.
The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
Hidaka D, Hayase E, Shiratori S, Hasegawa Y, Ishio T, Tateno T, Okada K, Goto H, Sugita J, Onozawa M, Nakagawa M, Kahata K, Endo T, Hashimoto D, Teshima T. Hidaka D, et al. Among authors: hasegawa y. Clin Transplant. 2018 Sep;32(9):e13361. doi: 10.1111/ctr.13361. Epub 2018 Aug 13. Clin Transplant. 2018. PMID: 30054935
Intestinal goblet cells protect against GVHD after allogeneic stem cell transplantation via Lypd8.
Ara T, Hashimoto D, Hayase E, Noizat C, Kikuchi R, Hasegawa Y, Matsuda K, Ono S, Matsuno Y, Ebata K, Ogasawara R, Takahashi S, Ohigashi H, Yokoyama E, Matsuo K, Sugita J, Onozawa M, Okumura R, Takeda K, Teshima T. Ara T, et al. Among authors: hasegawa y. Sci Transl Med. 2020 Jul 1;12(550):eaaw0720. doi: 10.1126/scitranslmed.aaw0720. Sci Transl Med. 2020. PMID: 32611682
Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
Zhang Z, Hasegawa Y, Hashimoto D, Senjo H, Kikuchi R, Chen X, Yoneda K, Sekiguchi T, Kawase T, Tsuzuki H, Ishio T, Ara T, Ohigashi H, Nakagawa M, Teshima T. Zhang Z, et al. Among authors: hasegawa y. Bone Marrow Transplant. 2022 May;57(5):775-780. doi: 10.1038/s41409-022-01619-4. Epub 2022 Feb 28. Bone Marrow Transplant. 2022. PMID: 35228711 Free article.
Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
Nishida M, Sugita J, Iwai T, Sato M, Kudo Y, Omotehara S, Horie T, Sakano R, Hasegawa Y, Yasumoto A, Cho Y, Teshima T. Nishida M, et al. Among authors: hasegawa y. Bone Marrow Transplant. 2022 Aug;57(8):1338-1340. doi: 10.1038/s41409-022-01717-3. Epub 2022 May 25. Bone Marrow Transplant. 2022. PMID: 35614317 No abstract available.
[Bing-Neel syndrome successfully treated with tirabrutinib].
Yokoyama K, Ohigashi H, Miyajima T, Miyashita N, Okada S, Hasegawa Y, Sugita J, Onozawa M, Hashimoto D, Teshima T. Yokoyama K, et al. Among authors: hasegawa y. Rinsho Ketsueki. 2022;63(8):870-875. doi: 10.11406/rinketsu.63.870. Rinsho Ketsueki. 2022. PMID: 36058857 Japanese.
4,796 results